Citadel's multistrategy flagship Wellington fund climbed 1.4% in January, following a 15.1% gain in 2024, according to the ...

Hedge fund Citadel has made a £305mn bet against drugmaker GSK, the biggest short position against the company in more than a decade.

Billionaire investor Ken Griffin's flagship hedge fund climbed in a volatile January, according to a person familiar with the returns. Citadel's multistrategy flagship Wellington fund rose 1.4% ...

The long-touted Midtown skyscraper being developed through a partnership that includes billionaire Ken Griffin is scheduled to kick off its public review next month, according to an application filed ...